Cognitive Care Innovation Advisor - Healthcare Executive Advisory Board Member

About Alzheimer’s Treatment Centers of America (ATCA) Alzheimer’s Treatment Centers of America uses Artificial Intelligence (AI) + Personalized Precision Medicine to transform the treatment of Alzheimer’s disease, dementia, and brain fog from Long COVID. This is not about research. This is about treating patients. ATCA goes beyond diagnosing Alzheimer’s and dementia to uncover and address root causes through our innovative treatment protocols. Our multidisciplinary team, which includes top business executives and medical professionals with expertise in virtual reality and artificial intelligence, is leading the rollout of ATCA Clinics across the U.S.

Why Now? Immediate Revenue: ATCA is expanding to a multi-clinic organisation incorporating a new prime location...We're Launching Our New Clinic in Palm Beach Gardens, Florida. The Alzheimer's Treatment Centers of America ATCA clinic Palm Beach Gardens/Jupiter is located on the first floor of a two storey building with the Cleveland Clinic as a neighboring tenant. It is located in one of the most affluent areas and has replaced a prior urgent care space which has resulted in high levels of uptake with appointments already booked as far as March. In-Network with Insurance: ATCA treatments are covered by Medicare, Medicare Advantage, and most major healthcare insurance providers. Proven Results: In a study using the AI protocol implemented by ATCA, 75% of patients with mild cognitive impairment experienced no further decline. FDA-Approved Treatment: Includes TB006, which is FDA-approved for compassionate use and has the potential to reverse dementias, including Alzheimer’s. Physician-Supported: ATCA’s protocols are backed by an experienced Medical Advisory Board of top doctors and scientists. See our Medical Advisory Board:

https://atca.ai/medical-advisory-board/

Key Achievements Proven AI Protocol: Combines cutting-edge AI and precision medicine to deliver highly personalized treatment solutions. Scalable Model: Clinics are designed to deliver a 44% EBITDA margin, supported by strong unit economics. Market Opportunity: The U.S. Alzheimer’s treatment market is valued at $355 billion, with a global opportunity of $1.5 trillion. Research-Driven Care: Clinics also serve as micro-research facilities to advance innovation and generate future revenue streams. Cognitive Care Innovation Advisor Job Description

ATCA is seeking a forward-thinking Cognitive Care Innovation Advisor to join its Medical Advisory Board and help shape the evolution of a next-generation model for cognitive and brain health care. This role is designed for senior healthcare leaders, clinicians, researchers, or innovators who have experience advancing new approaches to cognitive care, neurological health, or patient-centered innovation. As a Cognitive Care Innovation Advisor, you will help guide how ATCA evolves its treatment model beyond traditional paradigms by integrating emerging science, novel care approaches, and innovation-driven thinking into scalable clinical practice. You will work closely with ATCA’s executive leadership, clinical teams, research collaborators, and technology partners to refine how cognitive care is designed, delivered, and continuously improved across a growing national clinic network.

Responsibilities Include Cognitive Care Innovation Strategy: Provide strategic guidance on advancing innovative approaches to cognitive assessment, treatment pathways, and patient engagement. Care Model Evolution: Advise on how new research, therapies, behavioral interventions, and care methodologies can be integrated into ATCA’s precision medicine framework. Patient-Centered Innovation: Support the development of care models that improve patient experience, adherence, and long-term cognitive outcomes. Precision Medicine Integration: Guide how data-driven insights, biomarkers, AI tools, and longitudinal monitoring can support innovation in cognitive care delivery. Quality & Outcomes Focus: Review aggregated, de-identified outcomes data to assess the effectiveness of new care approaches and support continuous improvement. Interdisciplinary Collaboration: Collaborate with physicians, scientists, technologists, and executive leadership to align innovation initiatives with real-world clinical delivery. Future-State Planning: Provide insight into emerging trends in cognitive health, brain science, and care innovation that may inform ATCA’s long-term roadmap.

Why Join Us? Transform Patient Outcomes: Help advance a model of Alzheimer’s care that prioritizes early detection, prevention, and coordinated primary care involvement. Influence National Care Delivery: Play a meaningful role in shaping how primary care–informed cognitive care is delivered across a growing network of clinics nationwide. Collaborate with Leaders: Work alongside a world-class team of physicians, scientists, AI experts, and healthcare executives. Be Part of a Defining Moment: Join ATCA at a critical stage of expansion where primary care leadership directly impacts growth, outcomes, and legacy.

Compensation / Perks Equity Options: Receive stock options in recognition of your clinical leadership and advisory contributions to ATCA’s mission. Investment Access: Select advisory board members may be offered access to ATCA’s current financing round. Participation is optional and independent of the advisory role.

Equal Opportunity Commitment ATCA is committed to fostering an inclusive environment. We believe diversity drives innovation and welcome individuals from all backgrounds to join us in transforming Alzheimer’s treatment.